Evaluation of monooleine aqueous dispersions as tools for topical administration of curcumin: Characterization, in vitro and ex-vivo studies

Journal of Pharmaceutical Sciences

Volumn 102, Issue 7, 2013, Pages 2349-2361

  Puglia, Carmelo ^a   Cardile, Venera ^a   Panico, Anna Maria ^a   Crascì, Lucia ^a   Offerta, Alessia ^a   Caggia, Silvia ^a   Drechsler, Markus ^b   Mariani, Paolo ^c   Cortesi, Rita ^d   Esposito, Elisabetta ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BAYREUTH   (Germany)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Antioxidants; Cell culture; Chemical stability; in vitro models; Light scattering; Nanotechnology; ORAC assay; Percutaneous; Western blot analysis.; X ray diffractometry

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 2; DRUG CARRIER; INDUCIBLE NITRIC OXIDE SYNTHASE; POLOXAMER; SODIUM CHOLATE SODIUM CASEINATE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; DISPERSION; DRUG DIFFUSION; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; ENZYME INHIBITION; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MONOOLEINE AQUEOUS DISPERSION; PROTEIN EXPRESSION;

EID: 84879009752     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23605     Document Type: Article

References (49)

1. Sofat N, Ejindu V, Kiely P. 2011. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology 50:2157-2165.
2. Heraud F, Heraud A, Harmand MF. 2000. Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 59:959-965.
3. Aigner T, Kim HA. 2002. Apoptosis and cellular vitality: Issues in osteoarthritic cartilage degeneration. Arthritis Rheum 46:1986-1996.
4. Ding GJ, Fischer PA, Boltz RC, Schmidt JA, Colaianne JJ, Gough A, Rubin RA, Miller DK. 1998. Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem 273:28897-28905.
5. Ziskoven C, Jäger M, Kircher J, Patzer T, Bloch W, Brixius K, Krauspe R. 2011. Physiology and pathophysiology of nitrosative and oxidative stress in osteoarthritic joint destruction. Can J Physiol Pharmacol 89:455-466.
6. Abramson SB, Attur M, Amin AR, Clancy R. 2001. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535-541.
7. Regan E, Flannelly J, Bowler R, Tran K, Nicks M, Carbone BD, Glueck D, Heijnen H, Mason R, Crapo J. 2005. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum 52:3479-3491.
8. Henrotin Y, Kurz B. 2007. Antioxidant to treat osteoarthritis: Dream or reality? Curr Drug Targets 8:347-357.
9. Aggarwal BB, Sung B. 2009. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci 30:85-94.
10. Jurenka JS. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 14:141-153.
11. Pan MH, Huang TM, Lin JK. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486-494.
12. Siekmann B, Bunjes H, Koch MHJ, Westesen K. 2002. Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride/water phases. Int J Pharm 244:33-43.
13. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. 2005. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163-2173.
14. Yaghmur A, Glatter O. 2009. Characterization and potential applications of nanostructured aqueous dispersions. Adv Colloid Interface Sci 147:333-342.
15. Esposito E, Mariani P, Ravani L, Contado C, Volta M, Bido S, Drechsler M, Mazzoni S, Menegatti E, Morari M, Cortesi R. 2012. Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study. Eur J Pharm Biopharm 80:306-314.
16. Pecora R. 2000. Dynamic light scattering measurement of nanometer particles in liquids. J Nanopart Res 2:123-131.
17. Esposito E, Fantin M, Marti M, Drechsler M, Paccamiccio L, Mariani P, Sivieri E, Lain F, Menegatti E, Morari M, Cortesi R. 2008. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res 25:1521-1530.
18. Mariani P, Luzzati V, Delacroix H. 1988. Cubic phases of lipid containing systems. Structure analysis and biological implications. J Mol Biol 204:165-189.
19. Luzzati V, Delacroix H, Gulik-Krzywicki T, Mariani P, Vargas R. 1997. The cubic phases of lipids. Curr Top Membr 44:3-24.
20. Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB. 2010. Curcuminoids loaded lipid nanoparticles: Novel approach towards malaria treatment. Colloids Surf B 81:263-273.
21. Kligman AM, Christophers E. 1963. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:702-705.
22. Swarbrick J, Lee G, Brom J. 1982. Drug permeation through human skin. I. Effects of storage conditions of skin. J Invest Dermatol 78:63-66.
23. Bronaugh RL, Stewart RF, Simon M. 1986. Methods for in vitro percutaneous absorption studies VII: Use of excised human skin. J Pharm Sci 75:1094-1097.
24. Touitou E, Fabin B. 1988. Altered skin permeation of a highly lipophilic molecule: Tetrahydrocannabinol. Int J Pharm 43:17-22.
25. Siewert M, Dressman J, Brown CK, Shah VP. 2003. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 4:E7.
26. Esposito E, Ravani L, Contado C, Costenaro A, Drechsler M, Rossi D, Menegatti E, Grandini A, Cortesi R. 2013. Clotrimazole nanoparticle gel for mucosal administration. Mater Sci Eng C 33:411-418.
27. Wells JI. 1988. Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances, Chichester, UK: Ellis Hortwood.
28. Merrell JG, McLaughlin SW, Tie L, Laurencin CT, Chen AF, Nair LS. 2009. Curcumin-loaded poly(epsilon-caprolactone) nanofibres: Diabetic wound dressing with anti-oxidant and anti-inflammatory properties. Clin Exp Pharmacol Physiol 36:1149-1156.
29. Gustafsson J, Ljusberg-Wharen H, Almgrem M, Larsson K. 1997. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13:6964-6971.
30. Larsson K. 2000. Aqueous dispersion of cubic lipid/water phases. Curr Opin Colloid Interface Sci 5:64-69.
31. Buccheim W, Larsson K. 1987. Cubic lipid-protein-water phases. J Colloid Interface Sci 117:582-583.
32. Golding M, Sein A. 2004. Surface rheology of aqueous casein-monoglyceride dispersions. Food Hydrocoll 18:451-461.
33. Lindstrom M, Ljusberg-Wahren H, Larsson K, Borgstrom B. 1981. Aqueous lipid phases of relevance to intestinal fat digestion and absorption. Lipids 16:749-754.
34. Barauskas J, Misiunas A, Gunnarsson T, Tiberg F, Johnsson M. 2006. "Sponge" nanoparticle dispersions in aqueous mixtures of diglycerol monooleate, glycerol dioleate, and polysorbate 80. Langmuir 22:6328-6334.
35. Yu H, Huang Q. 2012. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem 60:5373-5379.
36. Lars N, Ashraf A. 2004. Stratum corneum keratin structure, function, and formation: The cubic rod-packing and membrane templating model. J Invest Dermatol 4:715-732.
37. Lopes LB, Ferreira DA, de Paula D, Garcia MT, Thomazini JA, Fantini MC, Bentley MV. 2006. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: In vitro and in vivo skin penetration of cyclosporin A. Pharm Res 23:1332-1342.
38. Wang YJ, Pan M-H, Cheng A-L, Lin L-I, Ho Y-S, Hsieh C-Y, Lin J-K. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867-1876.
39. Price LC, Buescher RW. 1996. Decomposition of turmeric curcuminoids as affected by light, solvent and oxygen. J Food Biochem 20:125-133.
40. Price LC, Buescher RW. 1997. Kinetics of alkaline degradation of the food pigments curcumin and curcuminoids. J Food Sci 62:267-269.
41. Tonnesen HH, Masson M, Loftsson T. 2002. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm 244:127-135.
42. Gallet G, Carroccio S, Rizzarelli P, Karlsson S. 2002. Thermal degradation of poly(ethylene oxide-propylene oxide-ethylene oxide) triblock copolymer: Comparative study by SEC/NMR, SEC/MALDI-TOF-MS and SPME/GC-MS. Polymer 43:1081-1094.
43. O'Dwyer SP, O'Beirne D, Eidhin DN, O'Kennedy BT. 2013. Effects of sodium caseinate concentration and storage conditions on the oxidative stability of oil-in-water emulsions. Food Chem 138:1145-1152.
44. Heck DE, Laskin DL, Gardner CR, Laskin JD. 1992. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 267:21277-21280.
45. Weinberg JB. 2000. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation. Immunol Res 22:319-341
46. Brouet I, Ohshima H. 1995. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206:533-540.
47. Chan MM, Huang HI, Fenton MR, Fong D. 1998. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55:1955-1962.
48. Sarkar FH, Li Y. 2004. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 555:53-64.
49. Hong J, Sang S, Park HJ, Kwon SJ, Suh N, Huang MT, Ho CT, Yang CS. 2006. Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives. Carcinogenesis 27:278-286.